Filing Details

Accession Number:
0001609351-16-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 18:09:50
Reporting Period:
2016-05-19
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 18:09:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609351 Spark Therapeutics Inc. ONCE Biological Products, (No Disgnostic Substances) (2836) 462654405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673526 Joseph Barge La 3737 Market Street
Suite 1300
Philadelphia PA 19104
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-19 7,500 $3.45 12,825 No 4 M Direct
Common Stock Disposition 2016-05-19 7,500 $46.87 5,325 No 4 S Direct
Common Stock Acquisiton 2016-05-20 2,500 $3.45 7,825 No 4 M Direct
Common Stock Disposition 2016-05-20 2,500 $50.00 5,325 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-05-19 7,500 $0.00 7,500 $3.45
Common Stock Employee Stock Option (right to buy) Disposition 2016-05-20 2,500 $0.00 2,500 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,883 2024-06-09 No 4 M Direct
29,429 2024-07-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200 Indirect Held by Reporting Person's immediate family members
Footnotes
  1. 25% vested November 11, 2014 and the remainder vests in equal quarterly installments over the following three years.
  2. 25% vested May 24, 2015 and the remainder vests in equal quarterly installments over the following three years.